# Atorvastatin Therapy on Xanthoma in Alagille Syndrome

> **NCT05488067** · PHASE4 · COMPLETED · sponsor: **Children's Hospital of Fudan University** · enrollment: 15 (actual)

## Conditions studied

- Alagille Syndrome
- Atorvastatin
- Xanthoma

## Interventions

- **DRUG:** atorvastatin

## Key facts

- **NCT ID:** NCT05488067
- **Lead sponsor:** Children's Hospital of Fudan University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-03-22
- **Primary completion:** 2024-08-01
- **Final completion:** 2024-08-01
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2026-03-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05488067

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05488067, "Atorvastatin Therapy on Xanthoma in Alagille Syndrome". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05488067. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*